Get a Free 5ml Mini Now Free 5ml Mini With Every Order of The Mantle
Moumoujus

MYRISTYL HYDROXYETHYL IMIDAZOLINE.

Insufficient Data CAS 6942-02-5 / ANTISTATIC, HAIR CONDITIONING

Myristyl Hydroxyethyl Imidazoline is a long-chain fatty acid derivative primarily incorporated into personal care formulations for its conditioning, emulsifying, and foam-boosting properties. It contributes to product stability and texture, though direct skin-specific benefits are not extensively documented.

Summary

Conditioning Agent Emulsifier Foam Booster Formulation Stabilizer Antistatic Agent (Hair)

Science

Mechanism of Action

This compound primarily functions by providing conditioning effects, stabilizing foam in cleansing products, and serving as an emulsifier to facilitate the blending of immiscible liquid phases. For hair applications, it and related hydroxyethyl imidazolines also exhibit antistatic properties, enhancing overall hair feel.

Research

Clinical Evidence

Low confidence
Effective range N/A
Optimal

N/A

Transparency

Dusting Analysis

Not commonly dusted

The Formula

Formulation

Solubility
Oil
Optimal pH N/A
0 7 14

Stability

Myristyl Hydroxyethyl Imidazoline, like other imidazoline-based compounds, is generally considered thermally stable. However, it is susceptible to hydrolysis under alkaline conditions, particularly at pH values exceeding 6.

Safety

Safety Profile

CIR Status
Not reviewed
Sensitization risk Low

No specific safety assessments from the Cosmetic Ingredient Review (CIR), Scientific Committee on Consumer Safety (SCCS), or Food and Drug Administration (FDA) have been published for Myristyl Hydroxyethyl Imidazoline. A general evaluation of 'long-chain alkyl hydroxyethyl imidazolines' suggests low acute dermal toxicity and indicates they are not expected to be skin sensitizers or genotoxic. However, it is important to note that some compounds within this broader group have demonstrated skin corrosion and irreversible eye damage at higher concentrations (e.g., 5% in water for CAS No. 95-38-5). GHS classifications for Myristyl Hydroxyethyl Imidazoline (CAS 6942-02-5) are 'Not determined' for oral, dermal, or inhalation toxicity in at least one database. For the chemically related Oleyl Hydroxyethyl Imidazoline, aggregated GHS data from ECHA C&L Inventory shows 'Danger' with the hazard statement 'H314: Causes severe skin burns and eye damage' in 70.4% of reported cases, though 29.6% report it does not meet GHS hazard criteria.

Your Skin

Skin Compatibility

No Normal
No Dry
No Oily
No Sensitive
Irritancy Unknown
Comedogenicity Unknown

Our Assessment

Verdict

Insufficient Data

While Myristyl Hydroxyethyl Imidazoline provides valuable formulation benefits like conditioning and emulsification, the absence of specific skin-centric efficacy studies and comprehensive safety assessments for this exact compound leads to insufficient data for a definitive verdict on its direct skincare application.

Related

Similar Ingredients

Finding similar ingredients…